EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome

Chang Hoon Lee iD, Tuan Minh Nguyen iD, Yongook Lee, Seoung Gyu Choi, Phuong Ngan Nguyen, Jung Ho Park, Mi Kyung Park iD

International Journal of Molecular Sciences · 31.12.2025 · 27 (1) · 450

DOI: 10.3390/ijms27010450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.12.2025. Verfasst von Chang Hoon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the NRF, BK21 FOUR program through the National Research Foundation, Ministry of Health and Welfare (MOHW), Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-Negative Breast Cancer (TNBC) remains the most aggressive breast cancer subtype, characterized by profound heterogeneity and a lack of effective targeted therapies. Although cytotoxic chemotherapy is the standard of care, the rapid emergence of resistance driven by cancer stem cells (CSCs), metabolic plasticity, and the tumor microenvironment limits long-term survival. This review highlights the paradigm shift in TNBC treatment from 2021 to 2025, moving beyond broad cytotoxicity to precision medicine. We first examine the limitations of earlier targeted therapies, such as PI3K/AKT/mTOR inhibitors, which failed due to compensatory feedback loops and toxicity. We then discuss emerging synthetic lethality strategies targeting the G2/M checkpoint (WEE1, ATR) and mitotic kinases (PLK1, TTK) to exploit genomic instability in TP53-mutant tumors. Furthermore, we explore how novel modalities like PROTACs and Antibody–Drug Conjugates (ADCs) are unlocking the “undrugged kinome,” including targets like TNIK, PTK7, and PAK4, which were previously inaccessible. Finally, we propose that future success lies in combinatorial strategies integrating these next-generation kinase inhibitors with ADCs and immunotherapies to dismantle therapeutic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDrug Resistance, NeoplasmProtein Kinase InhibitorsAntineoplastic AgentsHumansMolecular Targeted TherapyFemaleAnimalsProteolysis Targeting ChimeraNeoplastic Stem Cells

Stichwörter der Autor:innen

PROTACPTK7antibody-drug conjugatesdrug resistancetriple-negative breast cancerundrugged kinome

Substanzen

Protein Kinase InhibitorsAntineoplastic AgentsProteolysis Targeting Chimera

Autor:innen und Institutionen

  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea.
  • Department of Biomedical Science, Hwasung Medi-Science University, Hwaseong-si 18274, Republic of Korea.

ORCID-Profile: Chang Hoon Lee, Tuan Minh Nguyen, Mi Kyung Park

Förderung

  • Basic Science Research Program through the NRF
  • BK21 FOUR program through the National Research Foundation
  • Ministry of Health and Welfare (MOHW), Republic of Korea

Zitieren

APA

Lee, C. H., Minh Nguyen, T., Lee, Y., Choi, S. G., Nguyen, P. N., Park, J. H., & Park, M. K. (2025). Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome. International Journal of Molecular Sciences, 27(1), 450. https://doi.org/10.3390/ijms27010450

Vancouver

Lee CH, Minh Nguyen T, Lee Y, Choi SG, Nguyen PN, Park JH, et al. Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome. International Journal of Molecular Sciences. 2025;27(1):450. doi:10.3390/ijms27010450

BibTeX
@article{Lee2025,
  author = {Lee, Chang Hoon and Minh Nguyen, Tuan and Lee, Yongook and Choi, Seoung Gyu and Nguyen, Phuong Ngan and Park, Jung Ho and Park, Mi Kyung},
  title = {Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {450},
  doi = {10.3390/ijms27010450}
}
Kostenlos starten →